BlogInsights AMCP Nexus 2023 Healthcare Stakeholders Prepare for the Inflation Reduction Act (IRA) Medicare Price Negotiations AMCP Nexus 2023, held recently in Orlando, Florida, hosted a forum for healthcare stakeholders to…Richard ChumbleyNovember 2, 2023
Blog Considerations for the use of RWD and RWE to support regulatory decision-making for drug and biological products Alexandra Sosinsky, our Director, Pharmacoepidemiology & Safety, offers her thoughts on FDA’s recent guidance regarding…Richard ChumbleyOctober 11, 2023
Blog The evolution of real-world evidence Chris Pashos discusses the evolution of real-world evidence and argues that although more data sources…Casey FrushourFebruary 10, 2023
Blog Shining a light on rare disease: evidence challenges and solutions Catherine Tak Piech argues that specialists and a plethora of new technologies are now well…Casey FrushourJanuary 19, 2022
Blog Driving transformation through evidence and collaboration An interview with former ISPOR President Chris Pashos, now Board Member, Genesis Research, about his…Casey FrushourAugust 10, 2021
Blog A compelling story: The long and the short of market access Stephen Ralston describes how having a clear strategy with the correct evidence to support the…Casey FrushourJune 10, 2021